Global Clinical Site Accreditation Launches


Global Clinical Site Accreditation (GCSA) has launched with a commitment aimed at increasing clinical research and trial capacity and quality in the UK, as well as globally. GCSA awards a certification mark through an evidence-based approach.

“As a global clinical research organization, Parexel is focused on working with sites as a partner in the clinical development process,” said Agnieszka Gackowska, Senior Director, Global Site Solutions. “To this end, the ability to pivot in pandemic situations and conduct trials in potentially unpredictable situations—implementing new approaches like decentralized clinical trials—is we work together to bring new therapies to patients in need.”

GCSA is an assessment, improvement, and accreditation organization. A collaboration between Future Shaping Holdings Ltd, the parent company of IAOCR, and Develop Consulting.

For more information, click here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.